Vytrus Biotech S.A.
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. The company offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Ca… Read more
Vytrus Biotech S.A. (VYT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2022: 0.047x
Based on the latest financial reports, Vytrus Biotech S.A. (VYT) has a cash flow conversion efficiency ratio of 0.047x as of December 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€225.55K) by net assets (€4.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vytrus Biotech S.A. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Vytrus Biotech S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vytrus Biotech S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vytrus Biotech S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ildong Holdings Co Ltd
KO:000230
|
0.043x |
|
Revival Gold Inc
OTCQX:RVLGF
|
-0.077x |
|
Linedata Services S.A.
PA:LIN
|
0.143x |
|
Showbox Corp
KQ:086980
|
0.056x |
|
0JR0
LSE:0JR0
|
N/A |
|
NEBAG NA SF 0,02
F:NWR
|
N/A |
|
Data Image Corporation
TW:3168
|
0.054x |
|
Hwa Sung Ind
KO:002460
|
0.345x |
Annual Cash Flow Conversion Efficiency for Vytrus Biotech S.A. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Vytrus Biotech S.A. from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €7.29 Million | €1.84 Million | 0.253x | +47.95% |
| 2023-12-31 | €5.29 Million | €904.39K | 0.171x | +260.14% |
| 2022-12-31 | €4.75 Million | €225.55K | 0.047x | -54.97% |
| 2021-12-31 | €4.25 Million | €447.92K | 0.105x | +387.17% |
| 2020-12-31 | €3.61 Million | €-132.47K | -0.037x | -- |